Global Multiple Sclerosis Drugs Market Analysis 2016-2020 and Forecast 2021-2026

Table of Contents
1 Industry Overview
1.1 Multiple Sclerosis Drugs Industry
Figure Multiple Sclerosis Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Multiple Sclerosis Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Multiple Sclerosis Drugs
1.2.2 Downstream
Table Application Segment of Multiple Sclerosis Drugs
Table Global Multiple Sclerosis Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Multiple Sclerosis Drugs Market by Type
3.1 By Type
3.1.1 Oral
Table Major Company List of Oral
3.1.2 Injectable
Table Major Company List of Injectable
3.1.3 Intravenous
Table Major Company List of Intravenous
3.2 Market Size
Table Global Multiple Sclerosis Drugs Market 2016-2020, by Type, in USD Million
Figure Global Multiple Sclerosis Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Multiple Sclerosis Drugs Market 2016-2020, by Type, in Volume
Figure Global Multiple Sclerosis Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Multiple Sclerosis Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Multiple Sclerosis Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Biogen (Company Profile, Sales Data etc.)
4.1.1 Biogen Profile
Table Biogen Overview List
4.1.2 Biogen Products & Services
4.1.3 Biogen Business Operation Conditions
Table Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Teva Pharmaceutical (Company Profile, Sales Data etc.)
4.2.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
4.2.2 Teva Pharmaceutical Products & Services
4.2.3 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Merck KGaA (Company Profile, Sales Data etc.)
4.3.1 Merck KGaA Profile
Table Merck KGaA Overview List
4.3.2 Merck KGaA Products & Services
4.3.3 Merck KGaA Business Operation Conditions
Table Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Novartis (Company Profile, Sales Data etc.)
4.4.1 Novartis Profile
Table Novartis Overview List
4.4.2 Novartis Products & Services
4.4.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Bayer (Company Profile, Sales Data etc.)
4.5.1 Bayer Profile
Table Bayer Overview List
4.5.2 Bayer Products & Services
4.5.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Sanofi (Company Profile, Sales Data etc.)
4.6.1 Sanofi Profile
Table Sanofi Overview List
4.6.2 Sanofi Products & Services
4.6.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Acorda Therapeutics (Company Profile, Sales Data etc.)
4.7.1 Acorda Therapeutics Profile
Table Acorda Therapeutics Overview List
4.7.2 Acorda Therapeutics Products & Services
4.7.3 Acorda Therapeutics Business Operation Conditions
Table Business Operation of Acorda Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Questcor Pharmaceuticals (Company Profile, Sales Data etc.)
4.8.1 Questcor Pharmaceuticals Profile
Table Questcor Pharmaceuticals Overview List
4.8.2 Questcor Pharmaceuticals Products & Services
4.8.3 Questcor Pharmaceuticals Business Operation Conditions
Table Business Operation of Questcor Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Multiple Sclerosis Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Multiple Sclerosis Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Multiple Sclerosis Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Multiple Sclerosis Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Multiple Sclerosis Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Multiple Sclerosis Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Multiple Sclerosis Drugs Market Concentration, in 2020
Figure Europe Multiple Sclerosis Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Multiple Sclerosis Drugs MMarket Concentration, in 2020
Figure South America Multiple Sclerosis Drugs Market Concentration, in 2020
Figure Middle East & Africa Multiple Sclerosis Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacy
Figure Multiple Sclerosis Drugs Demand in Hospital Pharmacy , 2016-2020, in USD Million
Figure Multiple Sclerosis Drugs Demand in Hospital Pharmacy , 2016-2020, in Volume
6.1.2 Demand in Retail Pharmacy
Figure Multiple Sclerosis Drugs Demand in Retail Pharmacy , 2016-2020, in USD Million
Figure Multiple Sclerosis Drugs Demand in Retail Pharmacy , 2016-2020, in Volume
6.1.3 Demand in Online Pharmacy
Figure Multiple Sclerosis Drugs Demand in Online Pharmacy, 2016-2020, in USD Million
Figure Multiple Sclerosis Drugs Demand in Online Pharmacy, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Multiple Sclerosis Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Multiple Sclerosis Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Multiple Sclerosis Drugs Market Share in 2026, by Application, in USD Million
Table Multiple Sclerosis Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Multiple Sclerosis Drugs Market Growth 2021-2026, by Application, in Volume
Table Multiple Sclerosis Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Multiple Sclerosis Drugs Production 2016-2020, by Region, in USD Million
Table Multiple Sclerosis Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Multiple Sclerosis Drugs Market 2016-2020, by Region, in USD Million
Table Global Multiple Sclerosis Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Multiple Sclerosis Drugs Market 2016-2020, by Region, in Volume
Table Global Multiple Sclerosis Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Multiple Sclerosis Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Multiple Sclerosis Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Table
1. Table Upstream Segment of Multiple Sclerosis Drugs
2. Table Application Segment of Multiple Sclerosis Drugs
3. Table Global Multiple Sclerosis Drugs Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Injectable
5. Table Major Company List of Intravenous
6. Table Global Multiple Sclerosis Drugs Market 2016-2020, by Type, in USD Million
7. Table Global Multiple Sclerosis Drugs Market 2016-2020, by Type, in Volume
8. Table Global Multiple Sclerosis Drugs Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Multiple Sclerosis Drugs Market Forecast 2021-2026, by Type, in Volume
10. Table Biogen Overview List
11. Table Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Teva Pharmaceutical Overview List
13. Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Merck KGaA Overview List
15. Table Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Novartis Overview List
17. Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Bayer Overview List
19. Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Sanofi Overview List
21. Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Acorda Therapeutics Overview List
23. Table Business Operation of Acorda Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Questcor Pharmaceuticals Overview List
25. Table Business Operation of Questcor Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Global Multiple Sclerosis Drugs Sales Revenue 2016-2020, by Company, in USD Million
27. Table Global Multiple Sclerosis Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
28. Table Global Multiple Sclerosis Drugs Sales Volume 2016-2020, by Company, in Volume
29. Table Global Multiple Sclerosis Drugs Sales Volume Share 2016-2020, by Company, in Volume
30. Table Regional Demand Comparison List
31. Table Major Application in Different Regions
32. Table Multiple Sclerosis Drugs Demand Forecast 2021-2026, by Application, in USD Million
33. Table Multiple Sclerosis Drugs Demand Forecast 2021-2026, by Application, in Volume
34. Table Multiple Sclerosis Drugs Market Growth 2021-2026, by Application, in Volume
35. Table Multiple Sclerosis Drugs Market Share in 2026, by Application, in Volume
36. Table Multiple Sclerosis Drugs Production 2016-2020, by Region, in USD Million
37. Table Multiple Sclerosis Drugs Production 2016-2020, by Region, in Volume
38. Table Global Multiple Sclerosis Drugs Market 2016-2020, by Region, in USD Million
39. Table Global Multiple Sclerosis Drugs Market Share 2016-2020, by Region, in USD Million
40. Table Global Multiple Sclerosis Drugs Market 2016-2020, by Region, in Volume
41. Table Global Multiple Sclerosis Drugs Market Share 2016-2020, by Region, in Volume
42. Table North America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
43. Table North America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
44. Table Europe Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
45. Table Europe Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
46. Table Asia-Pacific Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
47. Table Asia-Pacific Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
48. Table South America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
49. Table South America Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
50. Table Middle East & Africa Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in USD Million
51. Table Middle East & Africa Multiple Sclerosis Drugs Market Size 2016-2020, by Country, in Volume
52. Table Multiple Sclerosis Drugs Market Forecast 2021-2026, by Region, in USD Million
53. Table Multiple Sclerosis Drugs Market Forecast 2021-2026, by Region, in Volume
54. Table Price Factors List

List of Figure
1. Figure Multiple Sclerosis Drugs Industry Chain Structure
2. Figure Global Multiple Sclerosis Drugs Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Multiple Sclerosis Drugs Market Growth 2016-2020, by Type, in Volume
4. Figure Global Multiple Sclerosis Drugs Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Multiple Sclerosis Drugs Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Multiple Sclerosis Drugs Market Concentration, in 2020
7. Figure Europe Multiple Sclerosis Drugs Market Market Concentration, in 2020
8. Figure Asia-Pacific Multiple Sclerosis Drugs MMarket Concentration, in 2020
9. Figure South America Multiple Sclerosis Drugs Market Concentration, in 2020
10. Figure Middle East & Africa Multiple Sclerosis Drugs Market Concentration, in 2020
11. Figure Multiple Sclerosis Drugs Demand in Hospital Pharmacy , 2016-2020, in USD Million
12. Figure Multiple Sclerosis Drugs Demand in Hospital Pharmacy , 2016-2020, in Volume
13. Figure Multiple Sclerosis Drugs Demand in Retail Pharmacy , 2016-2020, in USD Million
14. Figure Multiple Sclerosis Drugs Demand in Retail Pharmacy , 2016-2020, in Volume
15. Figure Multiple Sclerosis Drugs Demand in Online Pharmacy, 2016-2020, in USD Million
16. Figure Multiple Sclerosis Drugs Demand in Online Pharmacy, 2016-2020, in Volume
17. Figure Multiple Sclerosis Drugs Market Growth 2021-2026, by Application, in USD Million
18. Figure Multiple Sclerosis Drugs Market Share in 2026, by Application, in USD Million
19. Figure North America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
20. Figure North America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
21. Figure Europe Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
25. Figure South America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
26. Figure South America Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Multiple Sclerosis Drugs Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview